1
|
William B, Khan A, Mellor S, Naseer M, Abraham S. 166 ReAudit - Review of Elective Procedures for Pilonidal Disease in a Single Centre, Jan 2020 – Aug 2021. Br J Surg 2022. [DOI: 10.1093/bjs/znac039.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Review of elective procedures for pilonidal disease in a single centre, Jan 2020 – Aug 2021
Introduction
Pilonidal disease continues to be managed with a variety of surgical techniques. We review results with Bascom 2 operation comparing to other practices at our institution.
Method
All elective procedures for pilonidal disease reviewed from Jan 2020 to August 2021. Age, gender, previous emergency and elective procedures for pilonidal disease, follow-up, recurrence and dehiscence rates, all-cause morbidity was examined retrospectively.
Results
In the study period there were 44 procedures. Average age was 26.4 years (range 16–44). Male to female ratio was 2:1. Procedure techniques performed included modified Bascoms flap (20), excision and primary closure (20), excision and packing (3) and Rhomboid flap (1). The number of previous emergency and elective procedures in the cohort were 18 and 3 respectively. In 24 (55%) procedures there was documented follow up, at a mean time of 49 days (median 56 days, range 3–84). Overall modified Bascom dehiscence (partial / full) dehiscence and recurrence rates were 10% and 5% respectively. Overall median number of bed related days length of stay was 0 days (range 0–3 days).
Conclusions
The modified Bascoms procedure is both technically simple and reproducible and offers comparatively good dehiscence and recurrence rates relative to other pilonidal sinus procedures.
Collapse
Affiliation(s)
- B. William
- Sandwell And West Birmingham Hospitals, NHS Trust, West Bromwich, United Kingdom
| | - A.E. Khan
- Sandwell and West Birmingham Hospitals, NHS Trust, West Bromwich, United Kingdom
| | - S. Mellor
- Sandwell And West Birmingham Hospitals, NHS Trust, West Bromwich, United Kingdom
| | - M. Naseer
- Sandwell And West Birmingham Hospitals, NHS Trust, West Bromwich, United Kingdom
| | - S. Abraham
- Sandwell And West Birmingham Hospitals, NHS Trust, West Bromwich, United Kingdom
| |
Collapse
|
2
|
Bousquet J, Akdis CA, Jutel M, Bachert C, Klimek L, Agache I, Ansotegui IJ, Bedbrook A, Bosnic‐Anticevich S, Canonica GW, Chivato T, Cruz AA, Czarlewski W, Del Giacco S, Du H, Fonseca JA, Gao Y, Haahtela T, Hoffmann‐Sommergruber K, Ivancevich J, Khaltaev N, Knol EF, Kuna P, Larenas‐Linnemann D, Mullol J, Naclerio R, Ohta K, Okamoto Y, O’Mahony L, Onorato GL, Papadopoulos NG, Pfaar O, Samolinski B, Schwarze J, Toppila‐Salmi S, Ventura MT, Valiulis A, Yorgancioglu A, Zuberbier T, Pawankar R, Mubeccel A, Mona A, Emilio AC, Hasan A, Cristina AM, Zeinab A, Mostafa BE, Sergio B, Cristina B, Eric B, Bianca B, Elisabeth B, Larl‐Christian B, David B, Leif B, Attilio B, Sergio B, isabelle B, Jacques B, Louis‐Philippe B, Fulvio B, Christopher B, Roland B, Carmen B, Andrew B, William B, Fernan C, Davide C, Silvia C, Paulo C, Walter C, Vicky C, Kai‐Hakon C, Warner C, Thomas C, Lorenzo C, Alfonso CM, Niels C, Ekaterine C, George C, Derek C, Cemal C, Giorgio C, Ieva C, Sousa Jaime CD, del Carmen CD, André C, Linda C, Alvaro C, Adnan C, Ulf D, Frédéric DB, Diana D, Pascal D, Philippe D, Alain D, Ratko D, Maria DCT, Dejan D, Ruta D, Stephen D, Patrik E, Yehia E, Regina E, Bieren Julia E, Alessandro F, Wytske F, Mina G, Luis GRJ, Bilun G, Sonya G, José G, Maximiliano G, Maia G, Ineta G, Marta G, Antonieta GM, Adnan H, Elham H, Jonathan H, Martin H, Yunuen HV, Guido I, Carla I, Zhanat I, Edgardo J, Ewa J, Erika J, Sebastian J, Guy J, Ki‐Suck J, Jocelyne J, Igor K, Omer K, Fuat K, Przemyslaw K, Jussi K, Jorg K, Gerard K, Marek K, Mikael K, Violeta K, Amir L, Susanne L, Lan L, Marcus L, Michael L, Jing L, Philip L, Brian L, Karin LC, Bassam M, Mika M, Hans‐Jorgen M, Gailen M, Pedro M, Mohammad M, Juan‐José M, Cem M, Erik M, Eli M, Hans M, Jean‐Pierre M, Florin M, Neven M, Branislava M, Yousser M, Mathieu M, Mario M, Ralph M, Lars M, Antonella M, Tihomir M, Alla N, Leyla N, Kristof N, Laurent N, Robyn O, Kimihiro O, Brian O, Luigi PP, Isabella P, Petr P, Nilos P, Sim PH, Ruby P, Ana P, Bernard P, Constantinos P, Davor P, Wolfgang P, Todor P, Fabienne P, Paul P, Lars P, Emmanuel P, Claus R, Stella RM, Janet R, José Angelo R, Graham R, Nicolas R, Antonino R, Jose R, Nelson R, Lanny R, Philip R, Dermot R, Mario S, Joaquin S, Glenis S, Elie S, Nikolaos S, Estelle S, Juan‐Carlos S, Dirceu S, Talant S, Manuel S, Cristiana S, Rafael S, Timo S, Charlotte SU, Carel T, Peter‐Valentin T, Massimo T, Ioana T, Marilyn UP, Erkka V, Eric VG, Marianne VH, Olivier V, Petra V, Martin W, Dana W, Yun WD, Susan W, Magnus W, Dennis W, Barbara Y, Arzu Y, Osman Y, Mario Z, Mihaela Z. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy 2020; 75:2440-2444. [PMID: 32233040 DOI: 10.1111/all.14302] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 03/27/2020] [Indexed: 01/02/2023]
|
3
|
Hwang S, Johnson A, Fabbro S, Hastings J, Haverkos B, Chung C, Porcu P, William B. Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas: a single-institution experience. Br J Dermatol 2020; 183:386-387. [PMID: 32078154 DOI: 10.1111/bjd.18961] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S Hwang
- Division of Hematology, Ohio State University, Columbus, OH, USA
| | - A Johnson
- Division of Hematology, Ohio State University, Columbus, OH, USA
| | - S Fabbro
- Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA
| | - J Hastings
- Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA
| | - B Haverkos
- Blood Cancer and BMT Program, University of Colorado School of Medicine, Aurora, CO, USA
| | - C Chung
- Division of Dermatology, Department of Medicine, Ohio State University, Columbus, OH, USA
| | - P Porcu
- Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University, Philadelphia, PA, USA
| | - B William
- Division of Hematology, Ohio State University, Columbus, OH, USA
| |
Collapse
|
6
|
Querfeld C, Foss F, Porcu P, Kim Y, Pacheco T, Haverkos B, Halwani A, DeSimone J, William B, Pinter-Brown L, Seto A, Ruckman J, Landry M, Jackson A, Dickinson B, Sanseverino M, Rodman D, Rubin P, Marshall W. PH 1 TRIAL EVALUATING MRG-106, A MICRORNA-155 INHIBITOR, ADMINISTERED BY INTRATUMORAL, SUBCUTANEOUS, OR INTRAVENOUS DELIVERY IN CUTANEOUS T-CELL LYMPHOMA (CTCL) PATIENTS. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_149] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - F.M. Foss
- Hematology and Bone Marrow Transplantation; Yale Cancer Center; Woodbridge USA
| | - P. Porcu
- Hematologic Malignancies and Hematopoietic Stem Cell Transplantation; Sidney Kimmel Cancer Center at Jefferson; Philadelphia USA
| | - Y.H. Kim
- Dermatology; Stanford Cancer Institute; Stanford USA
| | - T. Pacheco
- Dermatology; University of Colorado School of Medicine; Aurora USA
| | - B. Haverkos
- Blood Cancer & BMT; University of Colorado School of Medicine; Aurora USA
| | - A.S. Halwani
- Hematology and Hematologic Malignancies; Huntsman Cancer Institute at the University of Utah; Salt Lake City USA
| | - J. DeSimone
- Melanoma and Skin Cancer Center; Inova Schar Cancer Institute; Fairfax USA
| | - B. William
- Hematology; The Ohio State University Comprehensive Cancer Center; Columbus USA
| | - L. Pinter-Brown
- Hematology/Oncology; University of California; Irvine Orange USA
| | - A. Seto
- R&D, miRagen Therapeutics; Boulder USA
| | | | - M. Landry
- R&D, miRagen Therapeutics; Boulder USA
| | | | | | | | - D. Rodman
- R&D, miRagen Therapeutics; Boulder USA
| | - P. Rubin
- R&D, miRagen Therapeutics; Boulder USA
| | | |
Collapse
|